87 related articles for article (PubMed ID: 21048319)
1. Treatment of breast cancer cells with proteasome inhibitor lactacystin increases the level of sensitivity to cell death induced by human immunodeficiency virus type 1.
Endo M; Gejima S; Endo A; Takamune N; Shoji S; Misumi S
Biol Pharm Bull; 2010; 33(11):1903-6. PubMed ID: 21048319
[TBL] [Abstract][Full Text] [Related]
2. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
3. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120).
Biard-Piechaczyk M; Robert-Hebmann V; Richard V; Roland J; Hipskind RA; Devaux C
Virology; 2000 Mar; 268(2):329-44. PubMed ID: 10704341
[TBL] [Abstract][Full Text] [Related]
4. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor.
Yuan W; Craig S; Si Z; Farzan M; Sodroski J
J Virol; 2004 May; 78(10):5448-57. PubMed ID: 15113923
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4.
Endo M; Inatsu A; Hashimoto K; Takamune N; Shoji S; Misumi S
Curr HIV Res; 2008 Jan; 6(1):34-42. PubMed ID: 18288973
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 heterogeneity in primary cells: possible role of ubiquitination.
Lapham CK; Romantseva T; Petricoin E; King LR; Manischewitz J; Zaitseva MB; Golding H
J Leukoc Biol; 2002 Dec; 72(6):1206-14. PubMed ID: 12488503
[TBL] [Abstract][Full Text] [Related]
7. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions.
Lum JJ; Schnepple DJ; Badley AD
AIDS; 2005 Jul; 19(11):1125-33. PubMed ID: 15990565
[TBL] [Abstract][Full Text] [Related]
8. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
Kozak SL; Heard JM; Kabat D
J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
[TBL] [Abstract][Full Text] [Related]
9. Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling.
Roggero R; Robert-Hebmann V; Harrington S; Roland J; Vergne L; Jaleco S; Devaux C; Biard-Piechaczyk M
J Virol; 2001 Aug; 75(16):7637-50. PubMed ID: 11462036
[TBL] [Abstract][Full Text] [Related]
10. The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.
Hayasaka H; Kobayashi D; Yoshimura H; Nakayama EE; Shioda T; Miyasaka M
PLoS One; 2015; 10(2):e0117454. PubMed ID: 25688986
[TBL] [Abstract][Full Text] [Related]
11. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
[TBL] [Abstract][Full Text] [Related]
13. Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding.
Basmaciogullari S; Babcock GJ; Van Ryk D; Wojtowicz W; Sodroski J
J Virol; 2002 Nov; 76(21):10791-800. PubMed ID: 12368322
[TBL] [Abstract][Full Text] [Related]
14. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
15. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
16. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
Mori T; Boyd MR
Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
[TBL] [Abstract][Full Text] [Related]
17. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
18. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
Borsetti A; Parolin C; Ridolfi B; Sernicola L; Geraci A; Ensoli B; Titti F
J Virol; 2000 Jul; 74(14):6689-94. PubMed ID: 10864687
[TBL] [Abstract][Full Text] [Related]
19. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
20. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4.
Espert L; Denizot M; Grimaldi M; Robert-Hebmann V; Gay B; Varbanov M; Codogno P; Biard-Piechaczyk M
J Clin Invest; 2006 Aug; 116(8):2161-72. PubMed ID: 16886061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
